CNTB (Connect Biopharma Holdings) FCF Yield % : -79.67 (As of Apr. 02, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Connect Biopharma Holdings FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Connect Biopharma Holdings's Trailing 12-Month Free Cash Flow is $-25.19 Mil, and Market Cap is $31.62 Mil. Therefore, Connect Biopharma Holdings's FCF Yield % for today is -79.67%.

The historical rank and industry rank for Connect Biopharma Holdings's FCF Yield % or its related term are showing as below:

CNTB' s FCF Yield % Range Over the Past 10 Years
Min: -79.67 Med: 0 Max: 0
Current: -79.67

CNTB's FCF Yield % is ranked worse than
80.37% of 1498 companies
in the Biotechnology industry
Industry Median: -15.56 vs CNTB: -79.67

Connect Biopharma Holdings's FCF Margin % for the quarter that ended in Jun. 2024 was -34.87%.

Connect Biopharma Holdings FCF Yield % Historical Data

The historical data trend for Connect Biopharma Holdings's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Connect Biopharma Holdings FCF Yield % Chart

Connect Biopharma Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

-32.31

-221.76

-74.17

Connect Biopharma Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
FCF Yield %	Get a 7-Day Free Trial					-220.55	-222.52	-101.06	-51.61	-20.03

Competitive Comparison of Connect Biopharma Holdings's FCF Yield %

For the Biotechnology subindustry, Connect Biopharma Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Connect Biopharma Holdings's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Connect Biopharma Holdings's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Connect Biopharma Holdings's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Connect Biopharma Holdings FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Connect Biopharma Holdings's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-48.224	/	65.02154
	=	-74.17%

Connect Biopharma Holdings's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-8.41	*	2	/	83.98608
	=	-20.03%

Connect Biopharma Holdings FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Connect Biopharma Holdings FCF Yield % Related Terms

Thank you for viewing the detailed overview of Connect Biopharma Holdings's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Connect Biopharma Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Connect Biopharma Holdings Ltd (NAS:CNTB) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

12265 El Camino Real, Suite 350, San Diego, CA, USA, 92130

Website

https://www.connectbiopharm.com

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.